Oral NRX 194204 Study in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
- First Posted Date
- 2009-08-24
- Last Posted Date
- 2009-09-03
- Lead Sponsor
- NuRx Pharmaceuticals, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT00964132
- Locations
- 🇺🇸
UCSD Moores Cancer Center, La Jolla,, California, United States
🇺🇸Dr. Pandit, Fountain Valley, California, United States
🇺🇸Somerset Oncology Hematology Associates, Somerville, New Jersey, United States
Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic Leukemia
Phase 2
- Conditions
- Acute Promyelocytic Leukemia
- Interventions
- Drug: NRX 195183 Soft Gelatin Capsule
- First Posted Date
- 2008-05-12
- Last Posted Date
- 2008-05-12
- Lead Sponsor
- NuRx Pharmaceuticals, Inc.
- Target Recruit Count
- 65
- Registration Number
- NCT00675870
- Locations
- 🇺🇸
Sarcoma Oncology Center, Santa Monica,, California, United States
© Copyright 2025. All Rights Reserved by MedPath